Sciecure Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIECURE PHARMA INC
SCIECURE PHARMA INC has three approved drugs.
Summary for Sciecure Pharma Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Sciecure Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciecure Pharma Inc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-002 | Mar 2, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sciecure Pharma Inc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sciecure Pharma Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209293-001 | Jun 12, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
